Clover Health Investments Corp
NASDAQ:CLOV
Clover Health Investments Corp
Non-Reccuring Items
Clover Health Investments Corp
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Clover Health Investments Corp
NASDAQ:CLOV
|
Non-Reccuring Items
-$288k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
UnitedHealth Group Inc
NYSE:UNH
|
Non-Reccuring Items
-$265m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Centene Corp
NYSE:CNC
|
Non-Reccuring Items
-$7.3B
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
|
|
Humana Inc
NYSE:HUM
|
Non-Reccuring Items
-$513m
|
CAGR 3-Years
-285%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Healthequity Inc
NASDAQ:HQY
|
Non-Reccuring Items
-$7.5m
|
CAGR 3-Years
49%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Elevance Health Inc
NYSE:ELV
|
Non-Reccuring Items
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Clover Health Investments Corp
Glance View
Clover Health Investments Corp. embarked on a mission to transform the healthcare landscape with its innovative approach as a next-generation Medicare Advantage insurer. Born out of the need to reduce inefficiencies and enhance care, Clover Health uses its proprietary technology platform, the Clover Assistant, to arm physicians with data-driven insights that facilitate informed decision-making at the point of care. By integrating technology with healthcare delivery, Clover targets not only the evident administrative wastage but also addresses the structural challenges faced by patients and providers alike. This unique integration of digital tools with a traditional insurance model sets Clover apart in an industry ripe for disruption. Revenue for Clover Health primarily comes from Medicare Advantage premiums, where it competes by offering cost-effective plans combined with improved service. The company augments its financial model through government reimbursements tied to patient outcomes and the quality of care. Central to this strategy is the effective use of data analytics to manage patient care, reduce medical costs, and improve customer satisfaction. This alignment of financial incentives—lowering costs while enhancing patient outcomes—fuels Clover’s growth narrative, positioning it as a key player in reshaping how Medicare Advantage operates at the intersection of technology and healthcare delivery.
See Also
What is Clover Health Investments Corp's Non-Reccuring Items?
Non-Reccuring Items
-288k
USD
Based on the financial report for Dec 31, 2024, Clover Health Investments Corp's Non-Reccuring Items amounts to -288k USD.
What is Clover Health Investments Corp's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 1Y
99%
Over the last year, the Non-Reccuring Items growth was 99%.